Low Dose Radiotherapy for Osteoarthritis

Low Dose Radiotherapy for Osteoarthritis

Recruiting N/A Interventional Study
Osteoarthitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
113 (estimated)
Sponsor
Abramson Cancer Center at Penn Medicine · Other
Who this trial is looking for

This trial is looking for adults with osteoarthritis (OA) that has lasted for more than three months. Participants will receive low dose radiotherapy and report any changes in pain and function after treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older
  • I have been diagnosed with osteoarthritis for more than 3 months
  • I have OA in my hips, knees, hands, shoulders, ankles, or elbows
  • I have not found relief from standard treatments for OA
  • I want to try a treatment before considering joint replacement
  • I can provide signed and dated consent to participate

You may not be able to join if

  • I am unable to complete the study instruments

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This single institution, multi-site, single arm prospective study will enroll patients with a history of OA and assess changes in pain and function after treatment with LDRT as measured by patient-reported outcomes.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years or older * Diagnosis of OA \>3 months in hips, knees, hands, shoulders, ankles or elbows. * Refractory to standard of care therapies for OA or those who are being considered for more aggressive interventional treatment such as joint replacement, but more conservative …
Contacts

Marlowe Estioko, BS, MS

267-343-6483

Marlowe.Estioko@Pennmedicine.upenn.edu

CONTACT

Sonya George, BS

267-760-7636

Sonya.George@PennMedicine.upenn.edu

CONTACT